Literature DB >> 7979995

Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak.

M Höhne1, E Schreier, M Roggendorf.   

Abstract

The variability of the hepatitis C virus genome was investigated in a group of German patients who developed chronic hepatitis C after parenteral administration of contaminated immunoglobulin to prevent Rh sensitization after pregnancy. The nucleotide and deduced amino acid sequence alterations of the E1 and the first hypervariable region of the E2 gene of the hepatitis C virus (HCV) genome from sera of two randomly selected patients were studied by comparison of HCV sequences obtained from the original inoculum (anti Rh immunoglobulin) and from patient sera collected in 1979 and 1989. All isolates were classified as subtype 1b but showed nucleotide insertions of up to 12 nucleotides at the cleavage site of E1/E2. Microheterogeneity of HCV genomes was found in the immunoglobulin supporting the quasispecies model of HCV distribution. Remarkable nucleotide exchanges over the 10 year period in the E1 region (0.9-5.2 x 10(-3) base substitutions per genome site per year) and especially in the first hypervariable region of the E2 gene (about 1.5 x 10(-2)) occurred. The HCV genome undergoes a selection of variants, though it is not known if this derives from mutation or selection of pre-existing rare variants.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979995     DOI: 10.1007/BF01311170

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  34 in total

1.  Marked sequence diversity in the putative envelope proteins of hepatitis C viruses.

Authors:  N Kato; Y Ootsuyama; T Tanaka; M Nakagawa; T Nakazawa; K Muraiso; S Ohkoshi; M Hijikata; K Shimotohno
Journal:  Virus Res       Date:  1992-02       Impact factor: 3.303

2.  Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.

Authors:  H Okamoto; S Okada; Y Sugiyama; K Kurai; H Iizuka; A Machida; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

3.  Long-term persistence of hepatitis C virus antibodies in a single source outbreak.

Authors:  S Dittmann; M Roggendorf; J Dürkop; M Wiese; B Lorbeer; F Deinhardt
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

4.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants.

Authors:  R R Lesniewski; K M Boardway; J M Casey; S M Desai; S G Devare; T K Leung; I K Mushahwar
Journal:  J Med Virol       Date:  1993-06       Impact factor: 2.327

6.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.

Authors:  N Kato; H Sekiya; Y Ootsuyama; T Nakazawa; M Hijikata; S Ohkoshi; K Shimotohno
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus.

Authors:  N Kato; Y Ootsuyama; S Ohkoshi; T Nakazawa; H Sekiya; M Hijikata; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1992-11-30       Impact factor: 3.575

9.  Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

Authors:  P Simmonds; F McOmish; P L Yap; S W Chan; C K Lin; G Dusheiko; A A Saeed; E C Holmes
Journal:  J Gen Virol       Date:  1993-04       Impact factor: 3.891

10.  Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.

Authors:  M Martell; J I Esteban; J Quer; J Genescà; A Weiner; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more
  9 in total

1.  Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort.

Authors:  J McAllister; C Casino; F Davidson; J Power; E Lawlor; P L Yap; P Simmonds; D B Smith
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 2.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

3.  Distribution of genotypes and response to alpha-interferon in patients with hepatitis C virus infection in Germany.

Authors:  H H Feucht; B Zöllner; M Schröter; A Hoyer; M Sterneck; S Polywka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

4.  Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus.

Authors:  A Zibert; W Kraas; H Meisel; G Jung; M Roggendorf
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Genotypes and virus load in patients with hepatitis C infection.

Authors:  H Hofmann
Journal:  Infection       Date:  1995 May-Jun       Impact factor: 3.553

6.  Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.

Authors:  Jannie Pedersen; Tanja B Jensen; Thomas H R Carlsen; Kristian Schønning; Peer Brehm Christensen; Alex Lund Laursen; Henrik Krarup; Jens Bukh; Nina Weis
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

7.  Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region.

Authors:  G Driesel; D Wirth; K Stark; R Baumgarten; U Sucker; E Schreier
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a.

Authors:  Isabelle Moreau; John Levis; Orla Crosbie; Elizabeth Kenny-Walsh; Liam J Fanning
Journal:  Virol J       Date:  2008-07-09       Impact factor: 4.099

Review 9.  Quasispecies and its impact on viral hepatitis.

Authors:  Esteban Domingo; Jordi Gomez
Journal:  Virus Res       Date:  2007-03-08       Impact factor: 3.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.